![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessWhy mild contrast medium-induced reactions are sometimes over-treated and moderate/severe reactions of internal organs are undertreated: a summary based on RadioComics
-
Article
Letter to the Editor: how to document adverse reactions induced by gadolinium based contrast agents? A plea for type A and type B reactions
-
Article
Open AccessEfficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
To gain a greater understanding of the potential of the Aurora kinase A inhibitor MLN8237 in the treatment of pediatric malignancies.
-
Article
Iodinated Contrast Agents Are not Forbidden in Patients with Iodine Allergy
-
Article
Drug treatment-induced downregulation of antiphospholipid antibodies in PAPS
Although low-dose methotrexate (MTX) has been used to treat several autoimmune diseases like lupus erythematosus, rheumatoid arthritis, etc., it has not yet been used to treat patients with primary antiphospho...
-
Article
Polyarteritis Nodosa Mimicking Peripheral Vascular Disease
-
Article
Association of inclusion body myositis with subacute cutaneous lupus erythematosus
We present the case of a 71-year-old man with inclusion body myositis combined with subacute cutaneous lupus erythematosus and dysphagia. Although inclusion body myositis is usually resistant to immunosuppres...